BETTEN-AID SIMPLE HEARTBURN RELIEF
  • Your heartburn meds are killing you!
    • Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID‐19: a meta‐analysis
    • Reflux Drugs Tied to Bone Fractures in Children
    • Heartburn drugs linked to fatal heart and kidney disease, stomach cancer
    • Millions of Canadians using acid-reflux drugs for too long, risking health side-effects
    • Using friendly bacteria to treat Irritable Bowel Syndrome
    • Proton Pump Inhibitors: How to Deprescribe These Nutrient Robbers
    • Pneumonia Risk with PPI Use Continues Past One Year, Researchers Say
    • Acidity and Heartburn Medications May Up Risk Of Pneumonia In The Elderly
    • Babies Given Antibiotics or Antacids May Be More Likely to Have Allergies, Study Finds
    • Study Links Popular Heartburn Drugs to Esophageal Cancer
    • The Purple Pill in the Red Zone
    • PPIs Linked to Pancreatic Cancer, Death
    • Guidelines for Limiting Unnecessary Use of Proton Pump Inhibitors
    • Superbug’ may depend on calcium to multiply
    • Some heartburn drugs linked with higher risk of death
    • Probiotics, Enzymes to Support Gut Health
    • Infants prescribed antacids for reflux have increased risk of bone fractures
    • How reflux drugs could raise fracture risk in babies
    • Heartburn Meds: Do They Do More Harm Than Good?
    • Day after Super Bowl, 16 million stay home on 'Super Sick Day'
    • Heartburn Medication Linked to Increased Risk of First Time Stroke
    • The Use Of Common Drugs For Heartburn Now Linked To Developing Stroke, Study Finds
    • Could common heartburn drugs increase stroke risk?
    • Stomach Flu More Common in PPI Users
    • Proton Pump Inhibitors May Reduce Efficacy of Capecitabine
    • Do This One Easy Thing If You Want Garbage In Your Cells
    • Proton Pump Inhibitor Lawsuits Mount
    • Study: PPI Acid Reflux Drugs Overused in People with GI Bleeds
    • PPI Heartburn Drugs Linked to Brain Problems, Fluid Build Up
    • Should you be taking stomach-acid reducers?
    • Dementia
    • Mental Health >
      • One-third of US adults may unknowingly use medications that can cause depression
      • Stomach acid drugs may cause depression
    • Heart Disease >
      • Giving PPIs and Antibiotics Together May Disrupt Heart Rhythm
      • Study Shows Heartburn Drugs Increase Risk of Cardiovascular Complications
    • Increased Infections >
      • AH-CHOO! THESE MEDS LINKED WITH HIGHER ALLERGY RISK IN KIDS
      • Acid Suppression Drugs Linked to Gastrointestinal Infections
      • PPIs increase risk for hepatic encephalopathy, spontaneous bacterial peritonitis
    • Kidney Failure >
      • ASN: PPIs associated with increased risk of kidney disease
      • Proton Pump Inhibitors May Increase Risk for Kidney Disease
      • Proton Pump Inhibitor Drugs Linked To Silent Kidney Damage
      • Popular OTC Acid Reflux Medicines May Carry Substantial Negative Side Effects, Studies Show
    • Osteoporosis >
      • New Concerns over Suspected Link Between Nexium and Osteoporosis
  • What is Betten-Aid?
    • Tummy Trouble Is On The Rise Among Americans, Gastrointestinal Experts Say
  • Store
  • A new Paradigm in Acid Reflux.
  • Natural vs. Synthetic
  • National group wants cancer warning labels on acid reflux drugs

Increased Infections

Picture

PPIs increase risk for hepatic encephalopathy, spontaneous bacterial peritonitis

Picture
07/2016
Dam G, et al. Hepatology. Special to the Idaho Statesman

Proton pump inhibitors increased the risk for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis and ascites, according to recent findings published in Hepatology.

“The trials from which our data originate were designed to determine the efficacy of satavaptan treatment, not to determine the mechanisms by which [proton pump inhibitors (PPIs)] may or may not cause [hepatic encephalopathy (HE)],” Gitte Dam, MD, PhD, in the department of hepatology and gastroenterology at Aarhus University Hospital in Denmark, and colleagues wrote. “Nonetheless, the findings that PPI use is a risk factor for [spontaneous bacterial peritonitis (SBP)] and that SBP is a risk factor for HE do provide support for the hypothesis that PPIs contribute to the development of HE by promoting translocation of gut bacteria.”
PPIs are designed to decrease gastric acid production and raise the pH of the stomach, but this can facilitate bacterial overgrowth, which can translocate the bacteria to the blood and lymph nodes, the researchers wrote. Dam and colleagues hypothesized that this PPI-induced bacterial translocation can lead to SBP and HE.
The researchers assessed the association between PPI use and the development of HE or SBP in 865 patients with cirrhosis and ascites. They used data from three 1-year trials of satavaptan (Aquilda, Sanofi-Aventis), a treatment for ascites. Afterward, they determined any association by using Cox regression.
Fifty-two percent of the patients used PPIs at some point during the trials. The cumulative 1-year risk for HE was 31% for those who used PPIs vs. 25% for those who did not. Compared with non-use, PPI use was associated with an increased risk for HE (HR = 1.36; 95% CI, 1.01-1.84) as well as overt HE (HR = 1.88; 95% CI, 1.21-1.91). It was also associated with an increased risk for SBP (HR = 1.72; 95% CI, 1.1-2.69).
These findings suggest that PPIs do increase the translocation of gut bacteria, the researchers concluded.
“The parallel increase in SBP risk points to a mechanism that goes through increased translocation of bacteria from the gut to the blood,” the researchers wrote. “Our findings suggest that prescription of PPIs to patients with cirrhosis at risk of HE needs an appropriate indication.” – by Will Offit

​



Dr. Eisenstein had spoken for years bugs do not like acid.  Betten Aid helps with re-flux without reducing the acid.

Powered by Create your own unique website with customizable templates.